Compare OLMA & SOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OLMA | SOC |
|---|---|---|
| Founded | 2006 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 648.0M |
| IPO Year | 2020 | N/A |
| Metric | OLMA | SOC |
|---|---|---|
| Price | $25.08 | $8.67 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 4 |
| Target Price | ★ $40.50 | $17.00 |
| AVG Volume (30 Days) | 2.8M | ★ 11.0M |
| Earning Date | 11-10-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.86 | $3.72 |
| 52 Week High | $36.26 | $35.00 |
| Indicator | OLMA | SOC |
|---|---|---|
| Relative Strength Index (RSI) | 47.46 | 57.39 |
| Support Level | $25.85 | $8.22 |
| Resistance Level | $36.26 | $11.00 |
| Average True Range (ATR) | 2.53 | 1.08 |
| MACD | -1.37 | 0.47 |
| Stochastic Oscillator | 0.71 | 61.41 |
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
Sable Offshore Corp is a Houston-based independent upstream company focused on responsibly developing the prolific Santa Ynez Unit in federal waters offshore California. The company is managed as one reportable segment, oil and gas.